MEDNAX

Pediatrix Medical Group, Inc. engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Pediatrix Medical's (MD) rising net patient service revenues will likely benefit its top line.

Why Investors Are Retaining Pediatrix Medical (MD) Stock Now

Start Time: 09:00 January 1, 0000 9:26 AM ET Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2023 Earnings Conference Call August 03, 2023, 09:00 AM ET Company Participants Jim Swift - CEO Marc Richards - EVP and CFO Charles Lynch - SVP, Finance and Strategy Conference Call Participants Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Second Quarter Earnings Conference Call.

Pediatrix Medical Group, Inc. (MD) Q2 2023 Earnings Call Transcript

The headline numbers for Pediatrix Medical Group (MD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Pediatrix Medical Group (MD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Pediatrix (MD) reiterates adjusted EBITDA guidance in the range of $235-$245 million for 2023 compared with $241 million in 2022.

Pediatrix (MD) Q2 Earnings Meet Estimates, Revenues Up Y/Y

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.39 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.47 per share a year ago.

Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.

Pediatrix Medical Group Reports Second Quarter Results

Progyny

Investors interested in stocks from the Medical Services sector have probably already heard of Pediatrix Medical Group (MD) and Progyny (PGNY). But which of these two stocks offers value investors a better bang for their buck right now?

MD vs. PGNY: Which Stock Is the Better Value Option?

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023.

Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

Why Is Pediatrix Medical Group (MD) Down 4.9% Since Last Earnings Report?

Investors are likely concerned about Pediatrix's (MD) lower enrollment in commercial insurance programs, escalating practice salaries and benefits and net borrowings.

Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Board Appoints Sylvia Young as Independent Director.

Pediatrix Board Appoints Sylvia Young as Independent Director

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference.

Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference

Pediatrix Medical Group, Inc. (NYSE:MD ) Q1 2023 Earnings Conference Call May 2, 2023 9:00 AM ET Company Participants Charles Lynch - SVP, Finance and Strategy Jim Swift - CEO Marc Richards - CFO Conference Call Participants Kevin Fischbeck - Bank of America Taji Phillips - Jefferies Jack Senft - William Blair A.J. Rice - Credit Suisse Kieran Ryan - Deutsche Bank Whit Mayo - SVB Securities Operator Ladies and gentlemen, thank you for standing by.

Pediatrix Medical Group, Inc. (MD) Q1 2023 Earnings Call Transcript

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.33 per share a year ago.

Pediatrix Medical Group (MD) Tops Q1 Earnings and Revenue Estimates

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.

Pediatrix Medical Group Reports First Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2023 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 2, 2023.

Pediatrix Medical Group 2023 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 2, 2023

Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Pediatrix Medical Group (MD) to Report a Decline in Earnings: What to Look Out for

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--James D. Swift, M.D.

James D. Swift, M.D., Elected to Pediatrix Board of Directors

Pediatrix (MD) anticipates 2023 adjusted EBITDA to be within $235-$245 million.

Pediatrix (MD) Q4 Earnings miss on High Operating Expenses

Pediatrix Medical Group, Inc. (NYSE:MD ) Q4 2022 Earnings Conference Call February 17, 2023 9:00 AM ET Company Participants Charles Lynch – Senior Vice President, Finance and Strategy Mark Ordan – Executive Chair Jim Swift – Chief Executive Officer Marc Richards – Chief Financial Officer Conference Call Participants Jack Senft – William Blair AJ Rice – Credit Suisse Pito Chickering – Deutsche Bank Whit Mayo – SVB Securities Kevin Fischbeck – Bank of America Rishi Parekh – JPMorgan Tao Qiu – Stifel Brian Tanquilut – Jefferies Operator Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode.

Pediatrix Medical Group, Inc. (MD) Q4 2022 Earnings Call Transcript

Pediatrix Medical Group (MD) delivered earnings and revenue surprises of -4.08% and 2.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Pediatrix Medical Group (MD) Lags Q4 Earnings Estimates

Pediatrix Medical Group Reports Fourth Quarter Results

Pediatrix Medical's (MD) fourth-quarter results are likely to reflect higher operating expenses and patient volume growth.

Pediatrix Medical (MD) to Post Q4 Earnings: What to Expect

Earnings Preview: Pediatrix Medical Group (MD) Q4 Earnings Expected to Decline

FORT LAUDERDALE, Fla.--( BUSINESS WIRE )--Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Friday, February 17, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2022. A detailed press release will be issued the morning of February 17, 2023 before the securities markets open.

News for MEDNAX Stock (MD)